CSA Medical CryoSpray Ablation System to be Manufactured and Distributed from Solectron Charlotte

  
    
  
  
    
      Solectron Corporation (NYSE:SLR), a leading provider of integrated 
      electronic supply chain services including design, manufacturing and 
      aftermarket services, has finalized an agreement with CSA Medical to 
      manufacture the company’s CryoSpray AblationTM 
      system. Following eight years of invention, testing, product development 
      and clinical trials, CSA Medical’s CryoSpray 
      Ablation system is rolling off the assembly line at Solectron’s 
      Charlotte, N.C. manufacturing facility.
    
    
      Based in Baltimore, MD, CSA Medical developed the CryoSpray Ablation 
      system, which freezes and destroys unwanted tissues found in the 
      esophagus, which, according to various reports arises from chronic acid 
      reflux. Peer-reviewed research estimates 65 million U.S. citizens suffer 
      from this condition. The 10 to 20 minute procedure uses a catheter to 
      transport and spray liquid nitrogen under low pressure through an 
      endoscope to freeze the tissue.
    
    
      Solectron's integrated supply chain services and medical manufacturing 
      capabilities enable CSA Medical to accelerate time-to-market without 
      making costly infrastructure investments. In addition to manufacturing 
      the CryoSpray Ablation system, Solectron manages orders and ships 
      directly to CSA Medical customers. CSA Medical and Solectron have worked 
      together since August 2006 to establish an optimized Lean supply chain 
      and manufacturing process.
    
    
      “We needed a contract manufacturing partner 
      with deep medical device expertise, complex systems mastery, and 
      end-to-end manufacturing and supply chain capabilities," said Freddy 
      Cannady, vice president, Operations, CSA Medical. "Solectron met this 
      criterion, and has been, and will continue, to be a valued partner 
      throughout this process.”
    
    
      “CSA Medical’s 
      CryoSpray Ablation System is an innovative approach to treating patients 
      with esophageal diseases, and we’re proud to 
      partner with them to help bring this product to market," said Dave 
      Busch, vice president, medical, Solectron. “Medical 
      device firms are under tremendous pressure to quickly develop high 
      quality products that meet physician and patient needs. Solectron is 
      able to provide customers like CSA Medical with the supply chain 
      expertise and the manufacturing flexibility that their complex products 
      require in a rapidly changing clinical environment.”
    
    
      “Solectron truly lives a Lean Six Sigma 
      culture. This has made it easier to integrate our world-class product 
      with a contract manufacturer that maintains compliance with stringent 
      U.S. and international regulatory requirements, and utilizes highly 
      efficient and precise continuous flow techniques. In my experience, few 
      do this well,” added Cannady. “We 
      needed a contract manufacturer who could provide one-stop support and 
      complete system-level integration. We utilized Solectron’s 
      packaging and testing site in Columbia, S.C. to design our ’green’ 
      packaging to ensure our product arrives safely anywhere in the world and 
      can be cycled back to manufacturing for continuous reuse.”
    
    
      Safe Harbor
    
    
      This release contains forward-looking statements within the meaning of 
      Section 27A of the Securities Act of 1933, as amended, and Section 21E 
      of the Securities Exchange Act of 1934, as amended, including, but not 
      limited to, the successful manufacture and distribution of the CryoSpray 
      Ablation system. These forward-looking statements involve a number of 
      risks and uncertainties, and are based on current expectations, 
      forecasts and assumptions. Actual outcomes and results could differ 
      materially. These risks and uncertainties include: unanticipated 
      challenges relating to manufacturing medical products; supply chain 
      management and logistics issues; product issues or problems relating to 
      the design of the product; business disruptions; the present and future 
      strength of the worldwide economy overall, and the market for this 
      medical product in particular; variations in demand forecasts and 
      orders; and our ability to retain key personnel. For a further list and 
      description of risks and uncertainties, see the reports filed by 
      Solectron with the Securities and Exchange Commission. Solectron 
      disclaims any intention or obligation to update or revise any 
      forward-looking statements, whether as a result of new information, 
      future events or otherwise.
    
    
      About CSA Medical
    
    
      CSA Medical, Inc. is committed to bringing the proven science of 
      cryotherapy to Endoscopy. The CSA™ System 
      allows therapeutic endoscopists to have the ability to quickly and 
      easily ablate unwanted tissue. The CSA™ 
      System utilizes a patented, FDA cleared technology that regulates and 
      transports a low-pressure cryogen through a 7 French catheter that is 
      easily passed through a standard endoscope. This rapid delivery system 
      of repetitive freeze-thaw cycles has been shown in clinical studies to 
      ablate pre-cancerous and cancerous cells with subsequent re-growth of 
      normal esophageal epithelium. CSA Medical is privately held and 
      headquartered in Baltimore, Maryland (www.CSAmedical.com).
    
    
      About Solectron
    
    
      Solectron Corporation is one of the world’s 
      largest providers of complete product lifecycle services. We offer 
      collaborative design and new product introduction, supply chain 
      management, Lean manufacturing and aftermarket services such as product 
      warranty repair and end-of-life support to leading customers worldwide. 
      Solectron works with the world's premier providers of networking, 
      telecommunications, computing, storage, consumer, automotive, 
      industrial, medical, self-service automation and aerospace and defense 
      products. The company's industry-leading Lean Six Sigma methodology 
      (Solectron Production System™) provides OEMs 
      with quality, flexibility, innovation and cost benefits that improve 
      competitive advantage. Based in Milpitas, Calif., Solectron operates in 
      more than 20 countries on five continents and had sales from continuing 
      operations of $10.6 billion in fiscal 2006. For more information, visit 
      us at www.solectron.com.
    
    
      Note: SOLECTRON and the Solectron logo are registered trademarks of 
      Solectron Corporation. The Solectron Production System, SPS, and 
      Solectron Supply Chain Solutions Suite are also trademarks of Solectron 
      Corporation. Other names mentioned are trademarks, registered trademarks 
      or service marks of their respective owners.